Hoersholm; March 26, 2015 - Medical Prognosis Institute A/S (MPI.CO) announced the Company's financial results for the year ended December 31, 2014.
Annual Report 2014
The Board of Directors for Medical Prognosis Institute A/S has today discussed the audited Annual Report for 2014. The Annual Report was approved and will be recommended for approval at the Annual General Meeting.
Annual General Meeting
The Annual General Meeting will be held on the 21 April 2015. A call for and Agenda will be sent in accordance with the Articles of Association.
Interim Report, Half Year per 30. June 2015
The Company announces half-year report for the period of 1. January - 30. June 2015 on 16 September 2015.
The Annual Report will be available at www.medical-prognosis.com.
Medical Prognosis Institute advances personalized medicine by partnering with cancer drug developers to apply its DRP diagnostic platform to streamline and de-risk clinical trials and drug development via biomarker optimization, patient stratification, and development of companion diagnostics.
For further information please contact
CEO Peter Buhl Jensen, Professor, MD, PhD
Cell Phone: (+45) 21 60 89 22
Certified Advisor: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark